Liprotamase
Idiopathic Pulmonary Fibrosis
Clinical trials
3
Developer
Anthera Pharmaceuticals
Overview
Liprotamase is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.
Liprotamase clinical trials
Explore related
Medical disclaimer. This page summarizes research about Liprotamase for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.